cd 2019 has been researched along with tretinoin in 5 studies
| Studies (cd 2019) | Trials (cd 2019) | Recent Studies (post-2010) (cd 2019) | Studies (tretinoin) | Trials (tretinoin) | Recent Studies (post-2010) (tretinoin) |
|---|---|---|---|---|---|
| 12 | 0 | 2 | 23,654 | 1,083 | 6,085 |
| Protein | Taxonomy | cd 2019 (IC50) | tretinoin (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.18 | |
| Adenosine receptor A3 | Homo sapiens (human) | 5.275 | |
| Retinoic acid receptor alpha | Homo sapiens (human) | 2.2542 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
| Retinoic acid receptor beta | Homo sapiens (human) | 0.7537 | |
| Retinoic acid receptor alpha | Mus musculus (house mouse) | 0.0057 | |
| Retinoic acid receptor gamma | Homo sapiens (human) | 0.0064 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
| Retinoic acid receptor gamma | Mus musculus (house mouse) | 0.004 | |
| Retinoic acid receptor beta | Mus musculus (house mouse) | 0.005 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.576 | |
| Nuclear receptor ROR-alpha | Homo sapiens (human) | 0.1995 | |
| Alpha-synuclein | Homo sapiens (human) | 3 | |
| Cellular retinoic acid-binding protein 1 | Gallus gallus (chicken) | 0.5233 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.358 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | 0.35 | |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.1995 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | 0.82 | |
| 60 kDa chaperonin | Escherichia coli | 6.7 | |
| 10 kDa chaperonin | Escherichia coli | 6.7 | |
| Nuclear receptor ROR-beta | Homo sapiens (human) | 0.1259 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardon, JM; Charpentier, B; Eustache, J; Martin, B; Michel, S; Millois, C; Shroot, B | 1 |
| Barret Kalindjian, S; Borthwick, AD; Brown, JT; Carlstedt, T; Clarke, E; Corcoran, JPT; Goncalves, MB; Grist, J; Hobbs, C; Jack, J; Jarvis, CI; Mills, M; Mumford, P; Pitcher, T | 1 |
| Elmazar, MM; Nau, H; Reichert, U; Shroot, B | 1 |
| Chiba, H; Iba, K; Ishii, S; Mori, M; Nuka, S; Sawada, N | 1 |
| Li, Y; MacLennan, AJ; Rogers, MB | 1 |
5 other study(ies) available for cd 2019 and tretinoin
| Article | Year |
|---|---|
Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.
Topics: Animals; Cell Differentiation; Magnetic Resonance Spectroscopy; Mice; Receptors, Retinoic Acid; Recombinant Proteins; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoids; Structure-Activity Relationship; Teratocarcinoma; Tretinoin; Tumor Cells, Cultured | 1995 |
Discovery and lead optimisation of a potent, selective and orally bioavailable RARĪ² agonist for the potential treatment of nerve injury.
Topics: Administration, Oral; Animals; Dogs; Drug Evaluation, Preclinical; Half-Life; Locomotion; Madin Darby Canine Kidney Cells; Neuronal Outgrowth; Optic Nerve Injuries; Oxadiazoles; Rats; Receptors, Retinoic Acid; Structure-Activity Relationship | 2019 |
Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Administration, Oral; Animals; Benzoates; Bone and Bones; Central Nervous System; Digestive System Abnormalities; Female; Mice; Naphthalenes; Pregnancy; Pregnancy Outcome; Receptors, Retinoic Acid; Retinoids; Tetrahydronaphthalenes; Tretinoin; Urogenital Abnormalities | 1996 |
All-trans retinoic acid inhibits dexamethasone-induced ALP activity and mineralization in human osteoblastic cell line SV HFO.
Topics: Alkaline Phosphatase; Benzoates; Biomarkers; Calcification, Physiologic; Cell Line; Dexamethasone; Enzyme Inhibitors; Humans; Naphthalenes; Osteoblasts; Osteocalcin; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoids; Teratogens; Tetrahydronaphthalenes; Tretinoin | 1997 |
A putative G-protein-coupled receptor, H218, is down-regulated during the retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
Topics: Animals; Benzoates; Bucladesine; Carcinoma, Embryonal; Cell Differentiation; Chromans; Down-Regulation; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Mice; Naphthalenes; Neoplasm Proteins; Phenotype; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Receptors, Retinoic Acid; Retinoids; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Tetrahydronaphthalenes; Tretinoin; Tumor Cells, Cultured | 1998 |